DE69333659D1 - Einschätzung von in trans-agierenden faktoren der allelen variation - Google Patents

Einschätzung von in trans-agierenden faktoren der allelen variation

Info

Publication number
DE69333659D1
DE69333659D1 DE1993633659 DE69333659T DE69333659D1 DE 69333659 D1 DE69333659 D1 DE 69333659D1 DE 1993633659 DE1993633659 DE 1993633659 DE 69333659 T DE69333659 T DE 69333659T DE 69333659 D1 DE69333659 D1 DE 69333659D1
Authority
DE
Germany
Prior art keywords
allel
assessment
trans
variation
aging factors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE1993633659
Other languages
English (en)
Other versions
DE69333659T2 (de
Inventor
Alexander Morrison
Allen Eisman
James Kelly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Garvan Institute of Medical Research
Original Assignee
Garvan Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Garvan Institute of Medical Research filed Critical Garvan Institute of Medical Research
Publication of DE69333659D1 publication Critical patent/DE69333659D1/de
Application granted granted Critical
Publication of DE69333659T2 publication Critical patent/DE69333659T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Train Traffic Observation, Control, And Security (AREA)
DE69333659T 1992-07-31 1993-08-02 Einschätzung von in trans-agierenden faktoren der allelen variation Expired - Fee Related DE69333659T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPL389392 1992-07-31
AUPL389392 1992-07-31
PCT/AU1993/000394 WO1994003633A1 (en) 1992-07-31 1993-08-02 Assessment of trans-acting factors allelic variation

Publications (2)

Publication Number Publication Date
DE69333659D1 true DE69333659D1 (de) 2004-11-18
DE69333659T2 DE69333659T2 (de) 2005-11-17

Family

ID=3776334

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69333659T Expired - Fee Related DE69333659T2 (de) 1992-07-31 1993-08-02 Einschätzung von in trans-agierenden faktoren der allelen variation

Country Status (8)

Country Link
US (1) US5593833A (de)
EP (1) EP0652975B1 (de)
JP (2) JP3465903B2 (de)
AU (1) AU673187B2 (de)
CA (1) CA2141300C (de)
DE (1) DE69333659T2 (de)
DK (1) DK0652975T3 (de)
WO (1) WO1994003633A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN058895A0 (en) * 1995-01-16 1995-02-09 Garvan Institute Of Medical Research Diagnostic method
AUPN445095A0 (en) * 1995-07-27 1995-08-17 Garvan Institute Of Medical Research Method of predicting bone density
NZ331041A (en) * 1996-01-17 2001-06-29 Timothy David Spector In vitro method for diagnosis of osteoporosis, atherosclerosis, cancer and immune disorders and medicaments
AU1299097A (en) * 1996-01-25 1997-08-20 Universite Laval Marker at the estrogen receptor gene for determination of osteoporosis predisposition
WO1997032998A2 (en) * 1996-03-08 1997-09-12 Isis Innovation Limited Materials and methods relating to the identification of a polymorphism associated with disease susceptibility
US5698399A (en) * 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis
GB9608133D0 (en) * 1996-04-19 1996-06-26 Gemini International Holdings Diagnostic method and apparatus
GB9610281D0 (en) * 1996-05-16 1996-07-24 Ralston Stuart H Diagnostic method and apparatus
JPH09327295A (ja) * 1996-06-10 1997-12-22 Chugai Pharmaceut Co Ltd ビタミンdレセプターアイソフォームタンパク質
US5691153A (en) * 1996-09-06 1997-11-25 Creighton University Genetic markers to detect high bone mass
AU3107097A (en) * 1997-06-13 1998-12-30 Chugai Seiyaku Kabushiki Kaisha Vitamin d receptor isoform proteins
JPH1175863A (ja) * 1997-07-10 1999-03-23 Kyowa Hakko Kogyo Co Ltd 25−ヒドロキシビタミンD3−1α−水酸化酵素および該酵素をコードするDNA
US6682920B1 (en) * 1997-09-26 2004-01-27 Onyx Pharmaceuticals, Inc. Compositions and methods for identifying PKB kinase inhibitors
GB9819764D0 (en) * 1998-09-10 1998-11-04 Oxagen Limited Method
GB9819769D0 (en) * 1998-09-10 1998-11-04 Oxagen Limited Method
US6416737B1 (en) 1998-11-19 2002-07-09 Board Of Trustees Of The University Of Arkansas Increasing bone strength with selected bisphosphonates
AU3442200A (en) * 1999-03-23 2000-10-09 Gemini Genomics Ab Genetic polymorphism and polymorphic pattern for assessing disease status, and compositions for use thereof
US6558905B1 (en) 1999-08-30 2003-05-06 Interleukin Genetics, Inc. Diagnostics and therapeutics for osteoporosis
US7723028B2 (en) 2000-08-30 2010-05-25 Interleukin Genetics, Inc. Diagnostics and therapeutics for osteoporosis
DE10103308A1 (de) * 2001-01-25 2002-08-14 Adnagen Ag Kit, Verfahren und Mikroarray zur Ermittlung der Prädisposition für Osteoporose
KR100459493B1 (ko) * 2002-01-31 2004-12-03 김기수 골다공증의 발생 위험을 예측하는 방법 및 이를 이용한골다공증의 유전적 위험 인자에 대한 진단 키트
US20030198316A1 (en) * 2002-04-17 2003-10-23 Piet Dewaele Osteoporosis screening method
KR20020092865A (ko) * 2002-11-01 2002-12-12 박창수 치과용 엑스레이 3차원입체영상 촬영기기
US7354712B2 (en) * 2003-04-30 2008-04-08 Century Technology, Inc. Estrogen receptor alleles that are predictive of increased susceptibility to bone fracture
WO2006091092A1 (en) * 2005-02-28 2006-08-31 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Polymorphism analysis of the estrogen receptor and vitamin d receptor to predict therapy responsiveness in the treatment of osteoporosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) * 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
AU1728088A (en) * 1987-04-30 1988-12-02 Biotechnology Research Partners Limited Hypertension-related blood tests useful as genetic markers
GB8920211D0 (en) * 1989-09-07 1989-10-18 Ici Plc Diagnostic method
US5260199A (en) * 1991-07-30 1993-11-09 Wisconsin Alumni Research Foundation Method of producing 1,25-dihydroxyvitamin D3 receptor protein
AU3322393A (en) * 1991-12-17 1993-07-19 Board Of Trustees Of The Leland Stanford Junior University Transcriptional cofactor regulation of expression

Also Published As

Publication number Publication date
JP3465903B2 (ja) 2003-11-10
JP3645247B2 (ja) 2005-05-11
US5593833A (en) 1997-01-14
AU4690093A (en) 1994-03-03
EP0652975A4 (de) 1998-12-23
WO1994003633A1 (en) 1994-02-17
JPH08501933A (ja) 1996-03-05
JP2004000235A (ja) 2004-01-08
CA2141300C (en) 2006-03-14
DE69333659T2 (de) 2005-11-17
DK0652975T3 (da) 2005-02-14
AU673187B2 (en) 1996-10-31
EP0652975B1 (de) 2004-10-13
EP0652975A1 (de) 1995-05-17
CA2141300A1 (en) 1994-02-17

Similar Documents

Publication Publication Date Title
DE69333659D1 (de) Einschätzung von in trans-agierenden faktoren der allelen variation
DE69307989T2 (de) Absenkung der schrittmacherfrequenz in abhängigkeit von der geleisteten arbeitsmenge
DE69431458T2 (de) Echtheitsüberprüfung von Gegenständen
FI935495A (fi) Näyttöjärjestely
DK73592D0 (da) Nyt enzym
MX156632A (es) Mejoras en aparato de clavos y similares
DE58901663D1 (de) I.m. injektionsformen von gyrase-inhibitoren.
DE69419510D1 (de) Verbesserungen bei der zerkleinerung von zellstoffbogen
DK165001C (da) Truck
DK105592D0 (da) Nyt enzym
DE69403955T2 (de) Verbesserungen von behältern
DK34892D0 (da) Nyt enzym
ATA219592A (de) Erfassung der neigung von grabungen
DE69528571D1 (de) Füllen von löchern und dergleichen in substraten
DE69314704D1 (de) In Situ Modifizierung der Carboxylgruppen von Gelatin
DK159606C (da) Malingsbeholder
FI905635A0 (fi) Maali
DE69302274T2 (de) Palette
DK99492D0 (da) Nyt enzym
DE69125675D1 (de) In situ-Herstellung von Diisopinocampheylchloroboran
DE69333241D1 (de) Reinigung von faktor ix
KR930702200A (ko) 파형 팔레트
ATA180192A (de) Palette
ITPR920023U1 (it) Leggio portatile
KR900002468U (ko) 십자가

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee